If any of your recently published papers are missing from this list, please let me know!
Evaluating niraparib versus active symptom control in patients with previously treated mesothelioma (NERO): a study protocol for a multicentre, randomised, two-arm, open-label phase II trial in UK secondary care centres.
Fennell D, Griffiths D, Eminton Z, Morgan-Fox A, Hill K, Ewings S, Stuart C, Johnson L, Mallard K, Nye M, Darlison L, Dulloo S, Cave J, Luo JL, Taylor P, Spicer J, Poile C, Bzura A, Griffiths G.
Evaluation of a COVID-19 fundamental nursing care guideline versus usual care: The COVID-NURSE cluster randomized controlled trial.
Richards DA, Bollen J, Jones B, Melendez-Torres GJ, Hulme C, Cockcroft E, Cook H, Cooper J, Creanor S, Cruickshank S, Dawe P, Doris F, Iles-Smith H, Kent M, Logan P, O'Connell A, Onysk J, Owens R, Quinn L, Rafferty AM, Romanczuk L, Russell AM, Shepherd M, Singh SJ, Sugg HVR, Coon JT, Tooze S, Warren FC, Whale B, Wootton S.
Dupilumab in type 2 airway inflammation-a step forward in targeted therapy for COPD.
Tan RVS, Aung HWW, Flynn C, Greening NJ, Brightling CE.
Perspectives of Patients With Chronic Respiratory Diseases and Medical Professionals on Pulmonary Rehabilitation in Pune, India: Qualitative Analysis.
Padhye R, Sahasrabudhe SD, Orme MW, Pina I, Dhamdhere D, Borade S, Bhakare M, Ahmed Z, Barton A, Modi M, Malcolm D, Salvi S, Singh SJ.
Enabling Adults With Severe Asthma to Exercise: A Qualitative Examination of the Challenges for Patients and Health Care Professionals.
Apps LD, Chantrell S, Majd S, Eglinton E, Singh SJ, Murphy AC, Green RH, Hudson N, Bradding P, Evans RA.
